Laura J. Taylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura J. Taylor has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Dafna Bar-Sagi
7 shared publications- Dafna Bar-Sagi
Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York
5 shared publications Anjaruwee S. Nimnual
Department of Molecular Genetics and Microbiology; Stony Brook University; Stony Brook, NY USA
2 shared publicationsHao-Hsuan Jeng
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, USA
2 shared publications- Veronica Lubkov
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA
2 shared publications - Alexandra E. Livanos
Department of Medicine, Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA
1 shared publication
Latest Publications
- 1 February 2014
- Published by Elsevier in Cancer Cell
- Vol. 25 (2) , 243-256
Wild-Type H- and N-Ras Promote Mutant K-Ras-Driven Tumorigenesis by Modulating the DNA Damage Response
- 1 February 2014
- Published by Elsevier in Cancer Cell
- Vol. 25 (2) , 243-256
Wild-Type H- and N-Ras Promote Mutant K-Ras-Driven Tumorigenesis by Modulating the DNA Damage Response
- Open Access
- 1 March 2012
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 26 (5) , 439-444
EZH2 couples pancreatic regeneration to neoplastic progression
Although the polycomb group protein Enhancer of Zeste Homolog 2 (EZH2) is well recognized for its role as a key regulator of cell differentiation, its involvement in tissue regeneration is largely unknown. Here we show that EZH2 is up-regulated following cerulein-induced pancreatic injury and is required for tissue repair by promoting the regenerative proliferation of progenitor cells. Loss of EZH2 results in impaired pancreatic regeneration and accelerates KRasG12D-driven neoplasia. Our findings implicate EZH2 in constraining neoplastic progression through homeostatic mechanisms that control pancreatic regeneration and provide insights into the documented link between chronic pancreatic injury and an increased risk for pancreatic cancer.
- 1 March 2012
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 26 (5) , 439-444
Open AccessEZH2 couples pancreatic regeneration to neoplastic progression
Although the polycomb group protein Enhancer of Zeste Homolog 2 (EZH2) is well recognized for its role as a key regulator of cell differentiation, its involvement in tissue regeneration is largely unknown. Here we show that EZH2 is up-regulated following cerulein-induced pancreatic injury and is required for tissue repair by promoting the regenerative proliferation of progenitor cells. Loss of EZH2 results in impaired pancreatic regeneration and accelerates KRasG12D-driven neoplasia. Our findings implicate EZH2 in constraining neoplastic progression through homeostatic mechanisms that control pancreatic regeneration and provide insights into the documented link between chronic pancreatic injury and an increased risk for pancreatic cancer.
- Open Access
- 1 January 2012
- Published by Springer Nature in Nature Communications
- Vol. 3 (1) , 1-8
Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
Mammalian cells contain three closely related ras genes, H-ras, K-ras and N-ras. Although in a given tumour type, oncogenic mutations are selectively observed in only one of the ras genes, the acquisition of the transformed phenotype has been shown to require the contribution of the normal products of the other ras genes. Here we demonstrate that oncogenic K-Ras promotes the activation of wild-type H- and N-Ras. This activation is mediated by oncogenic K-Ras-dependent allosteric stimulation of Sos and confers a growth advantage to oncogenic K-Ras harbouring cancer cells. These findings underscore the complementary functions of oncogenic and wild-type Ras in tumour cells and identify a potential new targeting strategy for Ras-driven tumours.
- 1 January 2012
- Published by Springer Nature in Nature Communications
- Vol. 3 (1) , 1-8
Open AccessSos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
Mammalian cells contain three closely related ras genes, H-ras, K-ras and N-ras. Although in a given tumour type, oncogenic mutations are selectively observed in only one of the ras genes, the acquisition of the transformed phenotype has been shown to require the contribution of the normal products of the other ras genes. Here we demonstrate that oncogenic K-Ras promotes the activation of wild-type H- and N-Ras. This activation is mediated by oncogenic K-Ras-dependent allosteric stimulation of Sos and confers a growth advantage to oncogenic K-Ras harbouring cancer cells. These findings underscore the complementary functions of oncogenic and wild-type Ras in tumour cells and identify a potential new targeting strategy for Ras-driven tumours.
- Open Access
- 1 September 2010
- Published by Taylor & Francis in Small GTPases
- Vol. 1 (2) , 89-97
Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b
Rac1, a ubiquitously expressed member of the Rho GTPase family, plays a pivotal role in the regulation of multiple cellular processes including cytoskeleton reorganization, cell growth, differentia...
- 1 September 2010
- Published by Taylor & Francis in Small GTPases
- Vol. 1 (2) , 89-97
Open AccessPerturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b
Rac1, a ubiquitously expressed member of the Rho GTPase family, plays a pivotal role in the regulation of multiple cellular processes including cytoskeleton reorganization, cell growth, differentia...
- 1 August 2010
- Published by Elsevier in Current Biology
- Vol. 20 (15) , 1372-1377
Feedback Regulation of Ras Signaling by Rabex-5-Mediated Ubiquitination
- 1 August 2010
- Published by Elsevier in Current Biology
- Vol. 20 (15) , 1372-1377
Feedback Regulation of Ras Signaling by Rabex-5-Mediated Ubiquitination
- 1 March 2007
- Published by Elsevier in Current Biology
- Vol. 17 (5) , 455-461
Spatial Regulation of EGFR Signaling by Sprouty2
- 1 March 2007
- Published by Elsevier in Current Biology
- Vol. 17 (5) , 455-461
Spatial Regulation of EGFR Signaling by Sprouty2
- 24 February 2003
- Published by Springer Nature in Nature Cell Biology
- Vol. 5 (3) , 236-241
Redox-dependent downregulation of Rho by Rac
Rac and Rho GTPases function as critical regulators of actin cytoskeleton remodelling during cell spreading and migration. Here we demonstrate that Rac-mediated reactive oxygen species (ROS) production results in the downregulation of Rho activity. The redox-dependent decrease in Rho activity is required for Rac-induced formation of membrane ruffles and integrin-mediated cell spreading. The pathway linking generation of ROS to downregulation of Rho involves inhibition of the low-molecular-weight protein tyrosine phosphatase (LMW-PTP) and then an increase in the tyrosine phosphorylation and activation of its target, p190Rho-GAP. Our findings define a novel mechanism for the coupling of changes in cellular redox state to the control of actin cytoskeleton rearrangements by Rho GTPases.
- 24 February 2003
- Published by Springer Nature in Nature Cell Biology
- Vol. 5 (3) , 236-241
Redox-dependent downregulation of Rho by Rac
Rac and Rho GTPases function as critical regulators of actin cytoskeleton remodelling during cell spreading and migration. Here we demonstrate that Rac-mediated reactive oxygen species (ROS) production results in the downregulation of Rho activity. The redox-dependent decrease in Rho activity is required for Rac-induced formation of membrane ruffles and integrin-mediated cell spreading. The pathway linking generation of ROS to downregulation of Rho involves inhibition of the low-molecular-weight protein tyrosine phosphatase (LMW-PTP) and then an increase in the tyrosine phosphorylation and activation of its target, p190Rho-GAP. Our findings define a novel mechanism for the coupling of changes in cellular redox state to the control of actin cytoskeleton rearrangements by Rho GTPases.
- 1 January 2003
- Published by Elsevier
- p. 711-714
The Role of Rac and Rho in Cell Cycle Progression
- 1 March 2000
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (5) , 2084-2093
Induction of the Cellular E2F-1 Promoter by the Adenovirus E4-6/7 Protein
The adenovirus type 5 (Ad5) E4-6/7 protein interacts directly with different members of the E2F family and mediates the cooperative and stable binding of E2F to a unique pair of binding sites in the Ad5 E2a promoter region. This induction of E2F DNA binding activity strongly correlates with increased E2a transcription when analyzed using virus infection and transient expression assays. Here we show that while different adenovirus isolates express an E4-6/7 protein that is capable of induction of E2F dimerization and stable DNA binding to the Ad5 E2a promoter region, not all of these viruses carry the inverted E2F binding site targets in their E2a promoter regions. The Ad12 and Ad40 E2a promoter regions bind E2F via a single binding site. However, these promoters bind adenovirus-induced (dimerized) E2F very weakly. The Ad3 E2a promoter region binds E2F very poorly, even via a single binding site. A possible explanation of these results is that the Ad E4-6/7 protein evolved to induce cellular gene expression. Consistent with this notion, we show that infection with different adenovirus isolates induces the binding of E2F to an inverted configuration of binding sites present in the cellular E2F-1 promoter. Transient expression of the E4-6/7 protein alone in uninfected cells is sufficient to induce transactivation of the E2F-1 promoter linked to chloramphenicol acetyltransferase or green fluorescent protein reporter genes. Further, expression of the E4-6/7 protein in the context of adenovirus infection induces E2F-1 protein accumulation. Thus, the induction of E2F binding to the E2F-1 promoter by the E4-6/7 protein observed in vitro correlates with transactivation of E2F-1 promoter activity in vivo. These results suggest that adenovirus has evolved two distinct mechanisms to induce the expression of the E2F-1 gene. The E1A proteins displace repressors of E2F activity (the Rb family members) and thus relieve E2F-1 promoter repression; the E4-6/7 protein complements this function by stably recruiting active E2F to the E2F-1 promoter to transactivate expression.
- 1 March 2000
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (5) , 2084-2093
Induction of the Cellular E2F-1 Promoter by the Adenovirus E4-6/7 Protein
The adenovirus type 5 (Ad5) E4-6/7 protein interacts directly with different members of the E2F family and mediates the cooperative and stable binding of E2F to a unique pair of binding sites in the Ad5 E2a promoter region. This induction of E2F DNA binding activity strongly correlates with increased E2a transcription when analyzed using virus infection and transient expression assays. Here we show that while different adenovirus isolates express an E4-6/7 protein that is capable of induction of E2F dimerization and stable DNA binding to the Ad5 E2a promoter region, not all of these viruses carry the inverted E2F binding site targets in their E2a promoter regions. The Ad12 and Ad40 E2a promoter regions bind E2F via a single binding site. However, these promoters bind adenovirus-induced (dimerized) E2F very weakly. The Ad3 E2a promoter region binds E2F very poorly, even via a single binding site. A possible explanation of these results is that the Ad E4-6/7 protein evolved to induce cellular gene expression. Consistent with this notion, we show that infection with different adenovirus isolates induces the binding of E2F to an inverted configuration of binding sites present in the cellular E2F-1 promoter. Transient expression of the E4-6/7 protein alone in uninfected cells is sufficient to induce transactivation of the E2F-1 promoter linked to chloramphenicol acetyltransferase or green fluorescent protein reporter genes. Further, expression of the E4-6/7 protein in the context of adenovirus infection induces E2F-1 protein accumulation. Thus, the induction of E2F binding to the E2F-1 promoter by the E4-6/7 protein observed in vitro correlates with transactivation of E2F-1 promoter activity in vivo. These results suggest that adenovirus has evolved two distinct mechanisms to induce the expression of the E2F-1 gene. The E1A proteins displace repressors of E2F activity (the Rb family members) and thus relieve E2F-1 promoter repression; the E4-6/7 protein complements this function by stably recruiting active E2F to the E2F-1 promoter to transactivate expression.